Articles related to NEUROLOGICAL DISORDERS

Neurologic manifestations of long COVID affect approximately 30% of patients regardless of vaccination status or initial disease severity, presenting significant implications for workforce productivity and healthcare delivery.

Prion diseases, while rare, pose significant challenges due to their fatal nature and lack of cure. The recent cases of CJD in hunters highlight the need for ongoing research and surveillance in both human and animal populations.

Recent systematic reviews suggest a subtle increase in NMOSD and MS risks post-COVID-19 vaccination, primarily affecting genetically susceptible individuals.

Manifest Technologies is spearheading the use of AI in developing targeted treatments for CNS disorders, aiming to refine patient selection in clinical trials and enhance therapeutic outcomes.

Physicians should be acutely aware of the heightened risk of neuroinvasive arboviral infections in patients treated with rituximab, necessitating a shift towards molecular diagnostic testing for timely and accurate detection.

Advanced biological aging, as measured by clinical biomarkers, increases one’s risk for dementia or stroke, despite adjustment for disease-specific risk factors. This finding underscores the potential of biological age as a predictor of neurological health.